Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030372280> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3030372280 endingPage "625" @default.
- W3030372280 startingPage "623" @default.
- W3030372280 abstract "Objective To investigate the serum level of visfatin, C-reactive protein (CRP) and monocyte chemoattractant protein-1 (MCP-1) in patients with polycystic ovarian syndrome (PCOS), and provide the basis for understanding the pathogenesis of PCOS. Meth-ods 94 patients with PCOS and 100 healthy subjects were divided into 4 subgroups according to their body mass index(BMI), including obese PCOS subgroup(n = 52), non - obese PCOS subgroup (n = 42), obese healthy subject subgroup (n = 43) and non - obese healthy subject (n = 57). Serum visfatin, CRP, MCP-1, sex hormone levels and metabolic parameters were measured by enzyme-linked immu-nosorbent assay (ELISA), automatic chemistry analyzer or chemiluminescent immunoassay. Results Serum levels of testosterone (T), lu-teiizing hormone (LH) and prolactin (PRL) in the PCOS group were significantly higher than those in healthy subjects group(P <0.05～0.01), and follicle-stimulating hormone (FSH) levels were significantly decreased in PCOS group(P<0.01). Serum levels of Visfatin, CRP, MCP-1,fasting insulin(Fins) and insulin resistance homa model (HOMA-IR) in the obese or non - obese PCOS subgroup were signif-icantly increased than that in the obese or non - obese healthy subjects subgroup respectively (P<0.01). Pearson correlation analysis showed that the visfatin, CRP and MCP-1 levels were positively related to BMI, FINS and HOMA-IR(r=0.323～0.675, P<0.01). Par-tial correlation showed that serum visfatin levels were correlated with HOMA-IR(r=0.491, P<0.01), and serum MCP-1 levels were cor-related with LH (r=0.267, P<0.05) in the PCOS group. Conclusion The patients with PCOS had higher visfatin, CRP and MCP-1 lev-els, and visfatin levels were positively correlated with insulin resistance. Obesity were involved in the chronic inflammation course in patients with PCOS.Key words: Polycystic ovary syndrome/BL; Cytokines/ME; C-reactive protein/ME; Monoeyte chemoattractant protein-1/ME" @default.
- W3030372280 created "2020-06-05" @default.
- W3030372280 creator A5040985281 @default.
- W3030372280 creator A5044812167 @default.
- W3030372280 creator A5065999911 @default.
- W3030372280 creator A5077879762 @default.
- W3030372280 date "2009-05-10" @default.
- W3030372280 modified "2023-09-26" @default.
- W3030372280 title "Change and significance of visfatin, C-Reactive protein and monocyte chemoattractant protein-1 in polycystic ovary syndrome patients" @default.
- W3030372280 doi "https://doi.org/10.3760/cma.j.issn.1008-1372.2009.05.015" @default.
- W3030372280 hasPublicationYear "2009" @default.
- W3030372280 type Work @default.
- W3030372280 sameAs 3030372280 @default.
- W3030372280 citedByCount "0" @default.
- W3030372280 crossrefType "journal-article" @default.
- W3030372280 hasAuthorship W3030372280A5040985281 @default.
- W3030372280 hasAuthorship W3030372280A5044812167 @default.
- W3030372280 hasAuthorship W3030372280A5065999911 @default.
- W3030372280 hasAuthorship W3030372280A5077879762 @default.
- W3030372280 hasConcept C126322002 @default.
- W3030372280 hasConcept C134018914 @default.
- W3030372280 hasConcept C2776782570 @default.
- W3030372280 hasConcept C2777391703 @default.
- W3030372280 hasConcept C2777911890 @default.
- W3030372280 hasConcept C2779064019 @default.
- W3030372280 hasConcept C2779306644 @default.
- W3030372280 hasConcept C2780221984 @default.
- W3030372280 hasConcept C2780942790 @default.
- W3030372280 hasConcept C30092816 @default.
- W3030372280 hasConcept C3018442814 @default.
- W3030372280 hasConcept C71315377 @default.
- W3030372280 hasConcept C71924100 @default.
- W3030372280 hasConceptScore W3030372280C126322002 @default.
- W3030372280 hasConceptScore W3030372280C134018914 @default.
- W3030372280 hasConceptScore W3030372280C2776782570 @default.
- W3030372280 hasConceptScore W3030372280C2777391703 @default.
- W3030372280 hasConceptScore W3030372280C2777911890 @default.
- W3030372280 hasConceptScore W3030372280C2779064019 @default.
- W3030372280 hasConceptScore W3030372280C2779306644 @default.
- W3030372280 hasConceptScore W3030372280C2780221984 @default.
- W3030372280 hasConceptScore W3030372280C2780942790 @default.
- W3030372280 hasConceptScore W3030372280C30092816 @default.
- W3030372280 hasConceptScore W3030372280C3018442814 @default.
- W3030372280 hasConceptScore W3030372280C71315377 @default.
- W3030372280 hasConceptScore W3030372280C71924100 @default.
- W3030372280 hasIssue "05" @default.
- W3030372280 hasLocation W30303722801 @default.
- W3030372280 hasOpenAccess W3030372280 @default.
- W3030372280 hasPrimaryLocation W30303722801 @default.
- W3030372280 hasRelatedWork W2118370555 @default.
- W3030372280 hasRelatedWork W2147921071 @default.
- W3030372280 hasRelatedWork W2153407704 @default.
- W3030372280 hasRelatedWork W2295584980 @default.
- W3030372280 hasRelatedWork W2354484079 @default.
- W3030372280 hasRelatedWork W2359335320 @default.
- W3030372280 hasRelatedWork W2359718006 @default.
- W3030372280 hasRelatedWork W2367946218 @default.
- W3030372280 hasRelatedWork W2373054088 @default.
- W3030372280 hasRelatedWork W2383109918 @default.
- W3030372280 hasRelatedWork W2384702729 @default.
- W3030372280 hasRelatedWork W2388131979 @default.
- W3030372280 hasRelatedWork W2390357808 @default.
- W3030372280 hasRelatedWork W2402258430 @default.
- W3030372280 hasRelatedWork W2417208298 @default.
- W3030372280 hasRelatedWork W2566502810 @default.
- W3030372280 hasRelatedWork W2612723130 @default.
- W3030372280 hasRelatedWork W3032632546 @default.
- W3030372280 hasRelatedWork W2184144478 @default.
- W3030372280 hasRelatedWork W2559765219 @default.
- W3030372280 hasVolume "11" @default.
- W3030372280 isParatext "false" @default.
- W3030372280 isRetracted "false" @default.
- W3030372280 magId "3030372280" @default.
- W3030372280 workType "article" @default.